SyGMa: Combining Expert Knowledge and Empirical Scoring in the Prediction of Metabolites

Abstract

Predictions of potential metabolites based on chemical structure are becoming increasingly important in drug discovery to guide medicinal chemistry efforts that address metabolic issues and to support experimental metabolite screening and identification. Herein we present a novel rule-based method, SyGMa (Systematic Generation of potential Metabolites), to predict the potential metabolites of a given parent structure. A set of reaction rules covering a broad range of phase 1 and phase 2 metabolism has been derived from metabolic reactions reported in the Metabolite Database to occur in humans. An empirical probability score is assigned to each rule representing the fraction of correctly predicted metabolites in the training database. This score is used to refine the rules and to rank predicted metabolites. The current rule set of SyGMa covers approximately 70 % of biotransformation reactions observed in humans. Evaluation of the rule-based predictions demonstrated a significant enrichment of true metabolites in the top of the ranking list: while in total, 68 % of all observed metabolites in an independent test set were reproduced by SyGMa, a large part, 30 % of the observed metabolites, were identified among the top three predictions. From a subset of cytochrome P450 specific metabolites, 84 % were reproduced overall, with 66 % in the top three predicted phase 1 metabolites. A similarity analysis of the reactions present in the database was performed to obtain an overview of the metabolic reactions predicted by SyGMa and to support ongoing efforts to extend the rules. Specific examples demonstrate the use of SyGMa in experimental metabolite identification and the application of SyGMa to suggest chemical modifications that improve the metabolic stability of compounds.

Determination and identification of estrogenic compounds generated with biosynthetic enzymes using hyphenated screening assays, high resolution mass spectrometry and off-line NMR

“…The development of MS based strategies enabling the identification of drug metabolites is regularly reported [22,23]. The implementation of algorithms pre and post acquisition to predict metabolites [24], to filter mass defects [25], neutral losses and isotope patterns [26] significantly enhances the rate of success in metabolite identification. By combining the advantages of on-line screening and high resolution mass spectrometry (HR-MS/MS) for first line structure identification, multidimensional data is obtained, and a quick selection can be made based on affinity and the modification introduced by e.g.…”

In silicoADME/T modelling for rational drug design

“…The main difference is the way such priorities are assigned. For example, the priority in META (Klopman et al , 1997Talafous et al 1994) is an integer between 1 and 9 that was optimized using a genetic algorithm; METEOR (Button et al 2003) has absolute and relative reasoning implemented; SyGMa (Ridder & Wagener, 2008) calculates a prior probability from a commercial metabolism database as the priority of each type of reaction. As expert systems typically assign the same priority to reactions of the same type without considering the influence of different substrates, additional calculations are often needed to reduce false positives.…”

Automated Annotation of Microbial and Human Flavonoid-Derived Metabolites

“…Large molecules with a molecular mass above 600 Da., which are less likely to be absorbed directly from the intestinal tract [ 29 ], were removed from the resulting library. To account for human metabolism after uptake, a number of phase 2 biotransformations [ 30 ] were applied, resulting in a total set of almost 5,000 compounds. Figure 6.2 illustrates the in silico generation metabolites for (epi)gallocatechin gallate.…”